Department of Chemistry, Deogiri College, Aurangabad 431 005, Maharashtra, India.
Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad 431 004, Maharashtra, India.
Bioorg Med Chem Lett. 2020 Nov 15;30(22):127592. doi: 10.1016/j.bmcl.2020.127592. Epub 2020 Sep 30.
In search of new active molecules against MCF-7, A549 and HepG2, tetrazole based pyrazoline and isoxazoline derivatives under both conventional and ultrasonic irradiation method were designed and efficiently synthesized. Structures of newly synthesized compounds 5a-h and 6a-h were characterized by H NMR, C NMR, MS and elemental analysis. Several derivatives were found to be excellent cytotoxic against MCF-7, A549 and HepG2 cell lines characterized by lower IC values (0.78-3.12 µg/mL). Compounds 5b and 5c demonstrated an antiproliferative effect comparable to that of CA-4. Western blot analysis revealed that, reported compounds accumulate more tubulin in the soluble fraction. Docking studies suggested that, binding of these compounds mimics at the colchicine site of tubulin. In vitro study revealed that the tetrazole based pyrazolines and isoxazolines may possess ideal structural requirements for further development of novel therapeutic agents.
为了寻找针对 MCF-7、A549 和 HepG2 的新型活性分子,我们设计并高效合成了基于四唑的吡唑啉和异噁唑啉衍生物,采用常规和超声辐射方法。新合成的化合物 5a-h 和 6a-h 的结构通过 1H NMR、13C NMR、MS 和元素分析进行了表征。一些衍生物被发现对 MCF-7、A549 和 HepG2 细胞系具有优异的细胞毒性,IC 值较低(0.78-3.12μg/mL)。化合物 5b 和 5c 表现出与 CA-4 相当的抗增殖作用。Western blot 分析表明,报道的化合物在可溶性部分积累了更多的微管蛋白。对接研究表明,这些化合物的结合模拟了微管蛋白的秋水仙碱结合位点。体外研究表明,基于四唑的吡唑啉和异噁唑啉可能具有进一步开发新型治疗剂的理想结构要求。